Podcasts about Cardiology

In this special TIO Congress edition of Parallax, Dr Ankur Kalra is joined by two of interventional cardiology's most influential voices: Professor Roxana Mehran, incoming President of the American College of Cardiology and Co-Course Director of TIO, and Professor Nicholas Van Mieghem, TIO Course Director. The conversation spans the evolution of online medical education, sex-specific differences in cardiovascular disease, and the challenge of translating clinical evidence into everyday practice. The guests explore sex as a biological variable across valve disease, plaque formation, and left ventricular remodeling, address the underdiagnosis of microvascular dysfunction in women, and examine persistent access barriers for female and non-white patients despite advances in trials such as SMART and RHEA. Professor Van Mieghem adds insights on modern TAVI planning and lifetime valve management, while Professor Mehran shares promising data on Factor XI inhibitors and the case for simplifying antithrombotic regimens. The episode closes on clinical inertia - with intravascular imaging uptake in the US still at just 12–15% despite a Class 1 indication, Professor Mehran outlines her ACC presidential vision: closing the gap between evidence and bedside practice, and reversing the troubling rise in cardiovascular morbidity and mortality. Questions and comments can be sent to podcast@radcliffe-group.com and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

In this insightful episode of The Better Life, Dr. Pinkston welcomes Dr. Sanjay Bhojraj, a board-certified interventional cardiologist who transitioned from emergency heart procedures to the world of functional and integrative medicine. Dr. Bhojraj shares his "origin story," explaining how a decade of performing "oil changes" on the heart led him to realize that conventional medicine was missing the most critical part of the equation: the mental, emotional, and spiritual lifestyle factors that drive chronic disease. The conversation dives deep into the "lost 20 years" where metabolic issues brew silently before a cardiac event occurs. Dr. Bhojraj introduces his Well12 program, a science-based approach to reversing insulin resistance and inflammation through light optimization, sleep, and whole-food nutrition. They also tackle the modern craze of GLP-1 medications, discussing how to use them as a "slingshot rather than a crutch" by prioritizing muscle preservation and long-term lifestyle shifts.See omnystudio.com/listener for privacy information.

Beta-blocker in non-obstructive hypertrophic cardiomyopathy, a head-to-head apixaban vs rivaroxaban RCT, diltiazem vs metoprolol combined with DOAC, and the accuracy of smart watches for AF are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback EMPATICC trial https://academic.oup.com/eurheartj/article/47/9/1034/8242490 II Beta-blocker in Non-obstructive HCM BB vs Calcium Channel Blocker in Non-obstructive HCM https://doi.org/10.1016/j.jacc.2025.11.028 RCT of Metoprolol in Patients With Obstructive HCM https://doi.org/10.1016/j.jacc.2021.07.065 III Apixaban vs Rivaroxaban for Bleeding Risk COBRRA Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2510703 AMPLIFY Trial (Apixaban) https://www.nejm.org/doi/10.1056/NEJMoa1302507 EINSTEIN Trial (Rivaroxaban) https://www.nejm.org/doi/full/10.1056/NEJMoa1007903 IV Diltiazem vs Metoprolol When Combined with DOAC Risk for Bleeding in AF Patients Using Apixaban or Rivaroxaban With Diltiazem https://www.acpjournals.org/doi/10.7326/ANNALS-25-01408 V Actual Clinical Use of Smart Watches CIRCA-DOSE Original Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.042622 Wearable Smartwatches for AF Detection After Ablation https://doi.org/10.1093/europace/euaf280 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we speak with Professor James Cnota of Cincinnati Children's Hospital about a recent report he co-authored from the SVR trial regarding the impact of tricuspid regurgitation (TR) on outcomes in hypoplastic left heart syndrome (HLHS). How common is TR seen in the HLHS patient and how does this change over time after surgical palliations? Is there an optimal time to intervene on the tricuspid valve in this patient group? What does the future hold for tricuspid surgical interventions? Dr. Cnota has the answers this week. doi: 10.1007/s00246-025-04122-x

Dr. Mary Rosser, obstetrician gynecologist and director of Fazzalari Women's Health at NewYork-Presbyterian The One and Columbia, joins us to explain how the endocrine system functions and how external chemicals can disrupt hormonal signals that influence metabolism, fertility, cancer risk, and long-term health. She details the most common sources of endocrine disruptors — including plastics, personal care items, cleaning products, and pesticides — and shares clear, manageable strategies for reducing everyday exposure. Dr. Rosser's guidance empowers listeners to make small, sustainable changes that can help protect hormonal well‑being.   Chapters: 00:00:00 — Understanding Hormones and Endocrine Disruptors 00:05:01 — Health Effects Linked to Endocrine Disruptors 00:09:55 — Everyday Sources and How to Reduce Exposure 00:17:28 — Can the Body Recover? Practical Steps and Final Takeaways   Key Topics Covered What hormones are and how the endocrine system works What endocrine disruptors are and how they interfere with hormone signaling How endocrine disruptors enter the body (skin, food, air) Health impacts: metabolism, fertility, cancer risk, and chronic conditions Common sources of disruptors (plastics, BPA, phthalates, cosmetics, cleaning products, pesticides, microplastics) Practical ways to reduce exposure in daily life How to monitor hormone health and when to talk to a doctor The body's ability to recover once exposure is reduced   Takeaway Message This episode empowers listeners to understand how everyday chemicals can interfere with the body's delicate hormonal system — and shows that small, practical changes in the products we use and the foods we choose can meaningfully reduce exposure.   Expert Guest Dr. Mary L. Rosser, M.D., Ph.D., NCMP is an obstetrician gynecologist and the director of Fazzalari Women's Health at NewYork-Presbyterian The One and Columbia. She is the Richard U. and Ellen J. Levine Assistant Professor of Women's Health (in Obstetrics and Gynecology) at Columbia University Vagelos College of Physicians & Surgeons. She joined the faculty of Obstetrics and Gynecology at Columbia University in April 2018 to provide routine gynecology care and to further develop a comprehensive well-woman program. She has been a practicing obstetrician gynecologist for more than 20 years, starting in private practice and then joining the faculty at Montefiore Medical Center in Bronx, NY. While at Montefiore, she created, launched, and led the forty-person Division of General Obstetrics and Gynecology. Dr. Rosser received her undergraduate degree at Emory University and a Ph.D. in Endocrinology at the Medical College of Georgia. She attended Wake Forest University School of Medicine and completed her residency at Emory University. She is also a NAMS Certified Menopause Practitioner, able to provide high-quality care for patients at menopause and beyond. Primary care and heart disease in women have always been areas of focus for Dr. Rosser. She conducted basic science research on heart disease during graduate school and was the Chair of the "Women & Heart Disease Physician Education Initiative" for District II of the American College of Obstetrics & Gynecology. She continues to conduct clinical studies around patient awareness and understanding of heart disease and well-woman care. Dr. Rosser serves on the Medical Leadership Team of the Go Red for Women movement of the American Heart Association and she is ACOG's liaison to the American College of Cardiology.  

In this episode of Focal Point, Sam, Amy and Sian from the IMV team discuss echocardiography, wildlife and teaching with Dr. Laurent Locquet Dipl. ECVIM-CA (Cardiology) MBA GPCert(VC) MRCVS DVM. Laurent graduated in 2015 from Ghent University, Belgium and worked in general practice for one year both abroad in South Africa as well as in Belgium, primarily with cats dogs and wildlife, before starting a rotating Internship in a busy referral centre in the UK. During his internship, Laurent obtained his certificate in Veterinary Cardiology. After completing his Internship, Laurent completed a Residency in Veterinary Cardiology at the University of Ghent before joining a busy referral practice in the Greater London area for one year before joining DWR Veterinary Specialists in 2022. In 2024, Laurent established the Veterinary Cardio Club, an online veterinary community for cardio-enthusiasts, including over 400 vets from over 80 countries in the world. Furthermore, he co-founded Skillvet in 2025, providing in-person lectures in 4 different continents in 2026. Lastly, he was involved in the development of the Sonus health app, the first AI driven veterinary cardiac screening and monitoring app. Laurent enjoys all aspects of veterinary Cardiology though he has a particular interest in procedures involving cardiopulmonary bypass, minimally invasive interventions and wildlife cardiology. How did a conversation in a sauna lead to a career examining the hearts of a diverse range of wildlife species? And where is technology taking cardiology and ultrasound? Listen in as we discuss all these topics and more! Got a question or suggestion? We would love to hear from you, and you can contact us using learning@imv-imaging.com. You can also check out our other learning resources on our Website, and our CPD courses, including our interactive Foundations in Echocardiography online course, via our Academy education platform. If you want more information on our in practice training, you can find it here.

Listener feedback, urgent AF ablation, AF ablation as a stroke-reducing therapy, implantable loop recorder accuracy, and HF management in the setting of serious disease are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Urgent AF ablations Urgent vs Elective AF Ablation in the US  https://www.jacc.org/doi/10.1016/j.jacep.2025.12.030 II AF Ablation Is Not Likely a Good Therapy for Stroke Reduction STABLED Trial https://jamanetwork.com/journals/jamaneurology/fullarticle/2845745 Catheter Ablation for AF Associated With Lower Incidence of Stroke https://doi.org/10.1093/eurheartj/ehw087 III Loop Recorders ILR Accuracy - Multicenter, Multidevice Comparison https://doi.org/10.1016/j.jacep.2025.12.039 IV Heart Failure Therapy when there is Cancer EMPATICC Trial https://doi.org/10.1093/eurheartj/ehaf705 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we listen in to a wonderful presentation that was delivered at the CHOP 2026 annual conference which was held in Phoenix, AZ. In this week's lecture we hear Dr. Gail Pearson of the NHLBI and NIH deliver her thoughts about the future of congenital heart research. Where does this master of research believe the next discoveries are going to arise from? What are the lessons we have learned from the PHN research endeavors over the past 25 years? Dr. Pearson offers her thoughts in this wonderful presentation which was the 24th Annual William J. Rashking Memorial Lecture at this conference. This presentation was delivered on 2.28.26.

Samantha Rux from OSF Healthcare joined Wake Up Tri-Counties to talk about a study that shows that regular exercise and weight training are more impactful for women than men. New research published in the Journal of the American College of Cardiology highlights greater exercise benefits for women compared to men. Tracking 400,000 individuals, the study found that women who work out regularly are 24% less likely to die early, compared to a 15% reduction for men. Women also saw a 36% lower risk of cardiovascular death, far outpacing men at just 14%. Nurse practitioner Mary O'Meara of OSF HealthCare urges women to add strength training to their routines, explaining that it can help combat muscle loss, improve heart health, and lower risks of dementia and osteoporosis. Proper protein intake and healthy fats are also recommended to maximize these benefits. A new study highlights a significant gender gap in heart health: women who exercise regularly experience a 36% lower risk of dying from cardiovascular events, compared to a 14% reduction in men. Mary O'Meara, a nurse practitioner at OSF HealthCare, points out that heart attacks in women are often missed, as symptoms can be subtle—fatigue, nausea, or heartburn—rather than intense chest pain. O'Meara emphasizes strength training and adequate protein intake, especially during menopause, to reduce risks of dementia, osteoporosis, and muscle loss. She also advocates for healthy fats like olive oil and fish oil in the diet, reminding women that it's never too late to start moving. Find more information at https://www.osfhealthcare.org/services/specialties/women.

This episode covers: Cardiology this Week: A concise summary of recent studies The future of guidelines in an era of big data and AI Exercise in hypertrophic cardiomyopathy Snapshots Host: Sabiha Gati Guests: Kostas Koskinas, Thomas F. Luescher, Michael Papadakis, Stephan Achenbach Want to watch that episode? Go to: https://esc365.escardio.org/event/2556 Want to watch the extended interview on The future of guidelines in an era of Big Data and AI, go to: https://esc365.escardio.org/event/2556?resource=interview Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode.  The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Sabiha Gati, Nicolle Kraenkel and Thomas F. Luescher have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.  Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Drs. Mateo Marin-Cuartas, CTSNet JANS Editor and cardiac surgeon at the University Department of Cardiac Surgery at Leipzig Heart Centre University Hospital in Leipzig, SN, Germany; and Samuel Heuts, a cardiothoracic surgeon in the Department of Cardiothoracic Surgery at Maastricht University Medical Center in Maastricht, LI, about a paper they authored titled “Updated 5-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low- to Intermediate-Surgical Risk,” published in Heart, a journal produced by the British Medical Journal. Chapters 00:00 Intro 01:51 JANS 1, 6-Year Outcomes TAVR vs SAVR 06:45 JANS 2, Evolut THV Postdilation 09:22 Video 2, TAVI in SAVR Explantation 11:10 JANS 3, High Risk Increasing Adoption of DCD 13:17 JANS 4, Lobar Quantitation for Assessment 15:16 Video 1, Narayana Robotic AVR 17:23 Video 3, Extended Resections Podcast 18:30 Dr. Marin-Cuartas & Heuts, TAVR vs SAVR 36:42 Upcoming Events 37:32 Instructional Video Competition 38:55 Career Center They discussed the motivations behind the creation of this paper and provided insights into its Bayesian hierarchical design. Key findings included the five-year all-cause mortality rates and the risk of stroke associated with the procedures. They also referenced other studies with similar findings, such as a recently published paper from the Journal of the American College of Cardiology on the “Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.” Finally, they explored the future of transcatheter aortic valve implantation and surgical aortic valve replacement.   Joel also highlights recent JANS articles on the six-year outcomes after transcatheter vs surgical aortic valve replacement in low-risk patients with aortic stenosis, postdilation of Evolut transcatheter heart valves, insights into current practices in the United States regarding increasing adoption of donation after circulatory death in high-risk heart transplant recipients, and the value of V/Q SPECT/CT lobar quantitation for pre-treatment assessment of lung malignancy.  In addition, Joel explores robotic-assisted aortic valve replacement, TAVI in SAVR explantation, and an episode of The Atrium podcast featuring host Dr. Alice Copperwheat speaking with Dr. Maninder Kalkat about extended resections. Before closing, Joel highlights upcoming events in CT surgery.    JANS Items Mentioned  1.) Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis  2.) Postdilation of Evolut Transcatheter Heart Valves: Insights From Bench Testing  3.) Increasing Adoption of Donation After Circulatory Death in High Risk Heart Transplant Recipients: Insights Into Current Practices in the United States  4.) The Value of V/Q SPECT/CT Lobar Quantitation for Pre-Treatment Assessment of Lung Malignancy  CTSNet Content Mentioned  1.) Robotic-Assisted Aortic Valve Replacement   2.) TAVI in SAVR Explantation: A Two-Step Technique for Successful Removal   3.) The Atrium: Extended Resections   Other Items Mentioned  1.) Updated 5-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low- to Intermediate-Surgical Risk  2.) The Lifeline  3.) Instructional Video Competition     4.) Career Center   5.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Beaucoup de personnes disent : « Je dors bien, je mange correctement, mais je suis épuisé(e), comme si mes batteries ne se rechargeaient plus. » Et cette sensation est souvent réelle. Ce ne sont pas toujours nos habitudes qui manquent d'énergie… ce sont parfois nos cellules.Au cœur de ce phénomène se trouve une molécule essentielle mais encore peu connue : la coenzyme Q10, ou CoQ10. Produite naturellement par l'organisme, elle est présente dans toutes les cellules, particulièrement dans celles qui consomment le plus d'énergie comme le cœur, le cerveau, les muscles et même la peau.Son rôle est central : elle permet aux mitochondries — les véritables centrales énergétiques de nos cellules — de produire l'énergie dont le corps a besoin pour fonctionner. Lorsque le niveau de CoQ10 diminue, la production d'énergie cellulaire ralentit.Or cette production baisse naturellement avec l'âge, dès 30 à 35 ans. Elle peut aussi diminuer davantage avec le stress, certaines maladies ou certains traitements comme les statines. Les conséquences peuvent se traduire par une fatigue persistante, une récupération plus lente ou un vieillissement cellulaire accéléré.Des travaux scientifiques s'y intéressent depuis plusieurs années. L'étude Q-SYMBIO, publiée dans le Journal of the American College of Cardiology, a notamment montré qu'une supplémentation en CoQ10 chez des patients insuffisants cardiaques améliorait l'énergie, la qualité de vie et la survie.La CoQ10 agit à la fois comme moteur énergétique et comme antioxydant protecteur pour les cellules. On en trouve dans l'alimentation, notamment dans les abats, le bœuf, le poulet, les poissons gras comme la sardine ou le maquereau, ainsi que dans certaines sources végétales comme les noix, les pistaches, les graines de sésame, les épinards ou les brocolis.Mais même avec une alimentation équilibrée, les apports restent faibles, souvent de quelques milligrammes par jour, alors que certaines études utilisent des doses bien plus élevées.Au fond, le vieillissement ne se résume pas aux rides : il commence souvent par une question d'énergie cellulaire.

Ogni giorno respiriamo, viviamo e ci muoviamo in un ambiente che ci influenza più di quanto pensiamo. Smog, rumore, luce artificiale, caldo e microplastiche non colpiscono solo i polmoni, ma possono avere effetti sul cuore e sul nostro equilibrio generale. Arrivano le nuove linee guida europee dell'European Society of Cardiology che ci aiutano a capire come proteggerci e vivere meglio, prestando attenzione a ciò che ci circonda. Ne parliamo con il professor Sergio Harari, dell'Unità Operativa di Pneumologia e di Medicina Interna dell'Ospedale San Giuseppe MultiMedica IRCSS e dell'Università di Milano.

This month on JHLT: The Podcast, the Digital Media Editors host two themed discussions around HIV in solid organ transplantation. The conversation begins with a discussion of the paper, "Early experience in heart transplantation utilizing donors with HIV," which appears in the March issue of JHLT. First author Omar Saeed, MD, MSc, of the Division of Cardiology at Montefiore Medical Center in New York, NY USA, joins the episode. The conversation includes discussion of: The ethics and evolution of the Montefiore program's transplant eligibility and criteria The role of the HOPE Act in the changes to the program Superinfection, viral strain analysis, and informed consent of organ recipients Long-term patient follow upsa nd how other centers can begin this research For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Return later this month for a broader conversation with an infectious diseases expert about HIV in transplantation. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

A diagnosis of HCM impacts mental as well as physical health. Hear from Lora Peppard, PhD, DNP, PMHNP-BC on interventions that nurses can use to support patients with HCM and lead to improved quality of life, adherence, and long-term health outcomes.Related resources:HCM & Mental Health: https://www.4hcm.org/hcm-and-mental-health American Psychiatric Nurses Association connection paradigmSpirituality wellness assessmentsMattering Science: Zach MercurioFlourishing Science: Christie BethelPCNA resources on HCM for providers and patientsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Whole food plant-based diets are safer than GLP-1 drugs and more effective than reducing meat for long-term health. #ObesitySolutions #PlantBased #WeightLoss

You Can't Retire From Purpose Dr. Alan Rozanski on the Six Domains of Health and What It Really Means to Age Well In this episode, I sit down with Dr. Alan Rozanski — cardiologist, lifestyle medicine physician, professor at the Icahn School of Medicine at Mount Sinai, and a founding pioneer of behavioral cardiology. With nearly 300 published articles, Dr. Rozanski has spent 40 years studying how our physical and mental behaviors shape heart health.What We CoverThe Aha Moment. Forty years ago, Dr. Rozanski watched patients' heart function deteriorate while simply talking about stress — just as it would on a treadmill. That observation launched a career exploring the mind-body connection.The Six Domains of Health.Physical Health — Exercise, resistance training, sleep, and nutrition. After 30, we lose 3–8% of muscle mass per decade. Resistance training can slow that decline.Mindset — Optimists live longer and show better biological markers. Gratitude costs nothing but attention.Emotional Well-Being — Chronic depression is one of the heart's greatest threats. Happiness builds resilience and extends life.Social Connection — The size and quality of your social network is a powerful predictor of longevity.Sense of Purpose — "You can retire from a job, but you can never retire your need for purpose."Stress Management — Mild challenge stress promotes growth. Toxic, uncontrollable stress damages health. Boredom carries its own quiet risks.The Biology. Mental states translate into physical disease through stress hormones, insulin resistance, inflammation, and even changes in brain structure. The good news: many of these changes are reversible.Mental Clutter. Scattered attention drains energy. Focused work sprints and intentional recovery help protect mental clarity.Healthcare Today. Dr. Rozanski speaks candidly about the geriatrician shortage, confusing nutritional guidelines, eroding doctor-patient time, and AI's emerging role in restoring it.Key Takeaway Health is not the absence of disease — it is vitality. That feeling is available at 19, 60, and 99. The six domains are six doorways. Wherever you are, one of them is a place to start.Connect with Dr. Rozanski Website: alanrozanski.com | LinkedIn: Dr. Alan RozanskiConnect with Dr. Alan Rozanski

A superb note on CPR and DNR orders, patients' vs doctors' preferences for statins, more on GLP-1s, another LAAC story, and some closing cautionary notes on PFA are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Addressing Inadequate Documentation of Unilateral DNR https://jamanetwork.com/journals/jama/fullarticle/2829203 Video: Can We Talk About CPR? https://www.youtube.com/watch?v=yTCRfY3ETvI Personal Reminiscences of CPR's Origin https://www.ajconline.org/article/S0002-9149(03)00977-9/pdf II Public Preferences for Statin Therapy Measuring Public Preferences for Statin Therapy https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2844660 III GLP-1 RA News ACHIEVE Trial https://doi.org/10.1016/S0140-6736(26)00202-3 IV New Trial in GLP-1 for Patients with AF Seminal-AF Trial https://clinicaltrials.gov/study/NCT06499857 V Relationship between Spontaneous Echo Contrast and LAAC Outcomes OCEAN-LAAC Trial https://doi.org/10.1016/j.jacep.2025.09.028 News Release on Upcoming LAAOS-4 trial  https://www.phri.ca/watchman/ Reading the "Smoke" -- Editorial on OCEAN-LAAC https://www.jacc.org/doi/10.1016/j.jacep.2025.10.029 VI Concluding Remarks on My Talk at Western AF Delayed Myocardial Ischemia and Malignant Arrhythmias After PFA https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.125.077983 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

This week we speak with Dr. John Brown who is the Harris B. Schumacker Professor Emeritus of Surgery at the University of Indiana. A congenital heart surgeon for over 45 years, Dr. Brown has performed more than 15,000 pediatric heart operations at Riley Hospital for Children and another 5000 heart operations in adults at IU and Methodist Hospitals. He performed the first pediatric heart transplant in Indiana and developed the first clinical use of the bovine jugular vein and valve for a pulmonary valve replacment in children. He also performed the only known twin to twin newborn heart transplant in the world. He has done and seen it all and has a unique perspective. How did he achieve so much and still have a succesful 56 year marriage to his wife Carol Ann? What is Dr. Brown most proud of in a career that is as prolific as his? What advice would he have have for the next generation? Prepare to be inspired by this master surgeon and friend and colleague of many in our field.

Dr. Patel is the Chief of Cardiology at Vitruvian Health and a board-certified interventional and structural cardiologist. He attended medical school at the Emory University School of Medicine in Atlanta, Georgia, and completed his residency training in internal medicine at the University of California San Francisco in San Francisco, California. He earned his Master in Business Administration degree at Northwestern University-Kellogg School of Management in Evanston, Illinois.He also completed his fellowships in cardiology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, and then further trained in structural and interventional cardiology at the Emory University School of Medicine in Atlanta, Georgia.https://vitruvianhealth.com/services/heart-vascular

Can You Reverse Heart Disease? Early Detection, AI Scans & The Future of CardiologyClick On My Website Below To Schedule A Free 15 Min Zoom Call:www.Over40FitnessHacks.comOver 40 Fitness Hacks SKOOL Group!Get Your Whoop4.0 Here!Dr. John Osborne - ClearCardiowww.clearcardio.comPodcast: Power of PreventionYouTube: Clear CardioIn this episode of Over 40 Fitness Hacks, I sit down with Dr. John Osborne, preventive cardiologist and founder of Clear Cardio, to talk about the biggest threat to longevity: cardiovascular disease.While much of my show has historically focused on fat loss, muscle building, and aesthetics, this conversation shifts toward what truly determines lifespan — heart health. Dr. Osborne makes it clear: if you don't have lifespan, healthspan doesn't matter.Dr. Osborne explains that cardiovascular disease has been the leading cause of death for over 120 years — responsible for roughly 40–45% of deaths, even during COVID. Globally, around 20 million people die each year from heart disease.The problem? We typically detect it far too late.Traditional cardiology focuses on finding severe blockages — the equivalent of detecting stage 4 cancer. But plaque (atherosclerosis) develops silently over decades. In fact, 85% of heart attacks occur in people without severe blockages detected beforehand, due to sudden plaque rupture.Even more alarming:Half of men and two-thirds of women experience a fatal event as their first symptom.Most people have no warning signs.Dr. Osborne's mission is early detection — what he calls the cardiac version of a colonoscopy.At Clear Cardio, they use:Advanced 640-slice Cardiac CT technologyAI-enhanced imaging capable of detecting plaque the size of a period at the end of a sentencePersonalized prevention plans based on decades of lipid and cardiovascular expertiseAccording to Dr. Osborne:99% of people have detectable plaqueOnly about 1% are completely plaque-freeMost people feel perfectly fine and have normal stress testsThe difference is that this technology detects plaque long before symptoms appear — when it's still reversible.Dr. Osborne emphasizes that we already have powerful, proven tools:Nutrition and exerciseBlood pressure and blood sugar managementAdvanced lipid therapiesTargeted medications when necessaryThe issue isn't lack of treatment — it's lack of early detection.Even those with strong genetic risk can reduce their risk by 50% with proper lifestyle habits. And for those who “picked the wrong ancestors,” there are still highly effective treatment options available.The cardiac CT scan also provides additional insights, including:Lung imagingFatty liver detectionBone densitySpine assessmentAll with extremely low radiation exposure — roughly equivalent to a chest X-ray, and far less than traditional nuclear stress tests.Dr. Osborne compares modern heart prevention to the early days of insulin in 1922 — a turning point that transformed diabetes care. He believes we're at a similar tipping point for heart disease.His ultimate goal?To eliminate plaque-driven heart disease entirely — and put himself out of business.Clear Cardio is currently operating in Dallas and Chicago, expanding to Manhattan, Miami, and other major cities, with the long-term goal of reaching high-population areas nationwide.If you're interested in online personal training or being a guest on my podcast, "Over 40 Fitness Hacks," you can reach me at brad@over40fitnesshacks.com or visit my website at:www.Over40FitnessHacks.comAdditionally, check out my Yelp reviews for my local business, Evolve Gym in Huntington Beach, at https://bit.ly/3GCKRzV

Dr. Patel is the Chief of Cardiology at Vitruvian Health and a board-certified interventional and structural cardiologist. He attended medical school at the Emory University School of Medicine in Atlanta, Georgia, and completed his residency training in internal medicine at the University of California San Francisco in San Francisco, California. He earned his Master in Business Administration degree at Northwestern University-Kellogg School of Management in Evanston, Illinois.He also completed his fellowships in cardiology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, and then further trained in structural and interventional cardiology at the Emory University School of Medicine in Atlanta, Georgia.https://vitruvianhealth.com/services/heart-vascular

From Evolut Low Risk data to nudges for physicians, plus the latest meeting news, this month had a lot to offer for the TCTMD team.

Candice K. Silversides, MD, FACC, Editor-in-Chief of JACC: Advances, interviews authors Sarah Godfrey MD, MPH, FACC and Caroline L. Doherty DNP, AGACNP-BC, FACC about their paper, "Identifying Palliative Care Competencies for Cardiology Fellowship Training: A National Delphi Consensus Study" published in the February 2026 issue of the Journal.

Heart disease is the leading cause of death for women, yet many women don't realize they're at risk—or don't know when their heart is asking for help. From subtle symptoms to risk factors that show up long before a heart attack, women's heart health is often misunderstood and overlooked. On this episode of the Healthier You podcast, Dr. Ashlee Williams speaks with Dr. Sneha Gadi, a board-certified cardiologist, about what every woman should know about her heart. Learn how heart disease can show up differently in women, what warning signs shouldn't be ignored, and simple, evidence-based steps that can help protect your heart at any age.  Learn more about Sneha Gadi, MD 

Dr. Patel is the Chief of Cardiology at Vitruvian Health and a board-certified interventional and structural cardiologist. He attended medical school at the Emory University School of Medicine in Atlanta, Georgia, and completed his residency training in internal medicine at the University of California San Francisco in San Francisco, California. He earned his Master in Business Administration degree at Northwestern University-Kellogg School of Management in Evanston, Illinois.He also completed his fellowships in cardiology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, and then further trained in structural and interventional cardiology at the Emory University School of Medicine in Atlanta, Georgia.https://vitruvianhealth.com/services/heart-vascular

EVOLUT Low Risk data, a provocative meta-analysis, DNR orders, targeted hypothermia, good news in HFpEF evidence, and GLP-1s as AF drugs are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I EVOLUT Low Risk 6-year Results and a 5-year Meta-Analysis of TAVR vs SAVR 6-Year Outcomes of TAVR vs SAVR https://www.jacc.org/doi/10.1016/j.jacc.2026.02.5063 EVOLUT Low Risk Trial at 2 years https://www.nejm.org/doi/full/10.1056/NEJMoa1816885 EVOLUT Low Risk Trial at 3 years https://www.jacc.org/doi/10.1016/j.jacc.2023.02.017 EVOLUT Low Risk Trial at 4 years https://www.jacc.org/doi/10.1016/j.jacc.2023.09.813 Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials https://www.jacc.org/doi/10.1016/j.jacc.2019.08.1034 TAVR vs SAVR 5-Year Outcomes - Systematic Review https://heart.bmj.com/content/early/2026/02/11/heartjnl-2025-327092 TAVR vs SAVR Updated Meta-Analysis of RCTs https://www.jacc.org/doi/10.1016/j.jacc.2024.12.031 UK TAVI Trial https://jamanetwork.com/journals/jama/fullarticle/2792251 Dr David Cohen on X https://x.com/djc795/status/2023556582030852172?s=46&t=zXMCUoVjSsdyemzWlzeBjA II DNR in the Hospital Inadequate Documentation of Unilateral DNR Orders https://jamanetwork.com/journals/jama/fullarticle/2829203 GeriPal Blog Unilateral DNR Orders https://geripal.org/unilateral-dnr-gina-piscitello-erin-demartino-will-parker/ III Yet another failure of Targeted Hypothermia 2-Year Follow-Up of TTM2 Trial https://jamanetwork.com/journals/jamaneurology/fullarticle/2845193 TTM2 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2100591 IV Good news in HFpEF Evidence ALT-FLOW II Trial https://doi.org/10.1093/ejhf/xuaf016 V GLP-1 as AF drugs Semaglutide as Adjunctive Therapy in Obesity-Related PAF https://doi.org/10.1093/europace/euag018 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review a fascinating very long-term surgical follow-up study from the team at Royal Children's Hospital in Melbourne reviewing over 30 year follow-up following the arterial switch operation for the treatment of transposition of the great vessels. What percentage of patients need reintervention by 30 years post neonatal repair? What anatomical sub-types are more likely to be associated with a need for reintervention and why? When intervention is required for neo-aortic or aortic root problems, can these usually be repaired or do they require replacement? Professor Igor Konstantinov from Melbourne shares his deep insights into this complex patient group. DOI: 10.1016/j.jtcvs.2025.09.008

Understanding and Managing Heart Health: In this Heart Health Month episode of the Intelligent Medicine Podcast, nutritionist Leyla Muedin addresses a listener's question about elevated cholesterol levels and calcium scores. Drawing on an article written by Dr. Hoffman, she emphasizes the importance of discussing statin use with a doctor, considering individual risk factors, and getting additional tests like VAPs, NMR, homocysteine, and lipoprotein levels. The episode explores the importance of vitamins K2 and folate in cardiovascular health, addressing nutritional deficiencies, and the impact of dietary choices on heart health.

February is American Heart Month. Cardiovascular disease is the leading cause of death in the US. What are the risk factors? How can you treat it? We'll talk with Dr. Mehnaz Rahman, Assistant Professor of Cardiology at LSU Health New Orleans

In this episode of Ask the Vet, Dr. Ann Hohenhaus is joined by her colleague Dr. Erin Achilles, Senior Veterinarian and Specialist in Cardiology at the Schwarzman Animal Medical Center. Together, they discuss how veterinary cardiologists play a critical role in helping pets live longer, healthier lives. Topics include:What veterinary cardiologists do and when your pet should see oneCommon types of acquired heart disease in dogs and catsHow to monitor your pet's resting respiratory rate and why it mattersTypes of congenital heart disease seen and treated at AMCTips to maintain your pet's heart healthAlso on this month's show:Trending animal story about how an Austrian cow, Veronika, has dazzled cognitive biologists through multi-purpose tool use Animal news, including research showing spider monkeys creating a complex social network to better find and gather foodPet Health Listener Q&A: How to know if your pet is experiencing hearing loss; understanding medication instruction labels; and whether one type of kitty litter is better than the restDo you have a pet question for Dr. Hohenhaus? Email askthevet@amcny.org to have your question answered on Ask the Vet's Listener Q&A.Follow us on Facebook, Instagram, LinkedIn, and TikTok!

JHLT: The Podcast returns with an episode  for our heart transplant colleagues, discussing the paper, "Barriers and opportunities in donation after circulatory death heart transplantation," from the February issue of JHLT. Featured on this episode is first author, Katherine G. Phillips, MD, of the Department of Cardiothoracic Surgery at NYU Langone, and co-author, Brian Wayda, MD, from the Division of Cardiology at NYU Langone. The discussion explores: Geographic variability on DCD heart utilization—why it happens and how to address Concerns around donor progression to circulatory arrest after life support withdrawal The volume of DCD hearts not utilized each year—and the gap between those successfully transplanted For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Have you longed to integrate your Christian faith into your patient care—on the mission field abroad, in your work in the US, and during your training? Are you not sure how to do this in a caring, ethical, sensitive, and relevant manner? This “working” session will explore the ethical basis for spiritual care and provide you with professional, timely, and proven practical methods to care for the whole person in the clinical setting. https://www.dropbox.com/scl/fi/qpah9kh1lttg6cm1jjop9/Bob-Mason-Ethics-of-Spiritual-Care-revised.pptx?rlkey=0emve2ja8282nv8xc4uinq1hg&st=9033htwx&dl=0

Utilizing shared decision-making in the diagnosis and management of hypertrophic cardiomyopathy can support positive outcomes for patients, family members and caregivers. Guests Kim Hecker, BSN, BA, RN, and Jillian Thorne, describe the process, and the impacts across all stages of the patient journey. References and related resources:2024 AHA/ACC Guideline for the Management of HCMTwice the Heart Foundation: https://www.instagram.com/twicetheheartfoundation/ PCNA resources on HCM for providers and patientsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Better Edge, Akhil Narang, MD, associate professor of Cardiology at Northwestern Medicine, examines the phase 3 ENHANCE trial, which evaluates a novel syringe-mounted surfactant device designed to generate uniform microbubbles and reduce variability in saline contrast echocardiography. By improving right-heart opacification and the fidelity of right-to-left shunt detection, the device aims to improve diagnostic accuracy and reduce rates of non-diagnostic and repeat studies. Rooted in Bluhm Cardiovascular Institute's commitment to advancing translational imaging, this trial may improve both workflow efficiency and patient care.

Ticagrelor vs prasugrel, a new LAAC device, pulsed field ablation AF results, lifestyle intervention in AF, the term "provider" vs "doctor," and coffee are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I TUXEDO-2 Trial TUXEDO-2 Trial https://jamanetwork.com/journals/jamacardiology/fullarticle/2844869 ISAR-REACT 5 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1908973 II VERITAS Study of Dual-Seal LAAO VERITAS Study https://doi.org/10.1016/j.jacep.2026.01.021 III PFA vs RF over 4 years Advent-LTO study https://www.nature.com/articles/s41591-026-04246-4 ADVENT Study https://www.nejm.org/doi/full/10.1056/NEJMoa2307291 SPHERE PER-AF Study https://www.nature.com/articles/s41591-024-03022-6 SINGLE SHOT CHAMPION Study https://www.nejm.org/doi/full/10.1056/NEJMoa2502280 BEAT PAROX-AF Trial https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf1115/8436829 IV What's in a Name — Use of the Term "Provider" Physicians Are Not Providers: The Ethical Significance of Names https://www.acpjournals.org/doi/10.7326/ANNALS-25-03852 V Coffee and Dementia Risk Coffee/Tea Intake and Dementia Risk https://jamanetwork.com/journals/jama/fullarticle/2844764 Mandrola Commentary: Enough With the Coffee Research and Other Distractions https://www.medscape.com/viewarticle/883709 VI Lifestyle interventions Post AF ablation Improving Outcomes of AF by Lifestyle Interventions https://academic.oup.com/eurheartj/article/47/6/669/8243674 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Why are compassion, kindness and humility critical to the care of patients in 2026? How can practitioners be taught these approaches and how does this 'triple gift' not only improve patient care but also professional interactions? Can this be taught? If so, what are the best ways? Professor Colin McMahon of Children's Health Ireland at Crumlin shares his deep insights into this important and oft-neglected aspect of being a caregiver. DOI: 10.1007/s00246-026-04161-yFollowing today's interview we also briefly speak with Professor Jack Rychik of Children's Hospital of Philadelphia about the upcoming CHOP 2026 meeting entitled "Cardiology 2026 - Together!". For those interested in possibly attending this meeting which begins on 2.28.26, take a look at the website below for more information:https://www.chop.edu/events/cardiology-2026

In this episode, Dr. Sergio Zanotti discusses a structured approach to ECMO emergencies, focusing on recognizing cardiac arrest, organizing the team response, and early ECMO troubleshooting to support key life-saving interventions. He is joined by Dr. Waqas Akhtar, a consultant at Guy's & St Thomas' NHS Foundation Trustin the United Kingdom. Dr. Akhtar completed full postgraduate certification in Cardiology, Intensive Care & General Internal Medicine, with a particular interest in cardiogenic shock, heart transplantation, and mechanical circulatory support Additional resources: British societies guideline on the management of emergencies in patients on extracorporeal membrane oxygenation. Waqas Akhtar, et al. Intensive Care Med 2025: https://pubmed.ncbi.nlm.nih.gov/41051555/ UK multisociety consensus statement on the emergency and resuscitation of patients with left-sided Impella support. Waqas Akhtar, et al. BMJ Journals 2026: https://heart.bmj.com/content/early/2025/12/17/heartjnl-2025-326896 Books mentioned in this episode: His Dark Materials Series: The Golden Compass; The Subtle Knife; The Amber Spyglass: https://bit.ly/4cmSXgB

In this episode, host Courtney Allison speaks with Dr. Jessica Hennessey, cardiologist at NewYork‑Presbyterian and Columbia, about the trend of cozy cardio and how accessible, home‑based movement can support cardiovascular health. Dr. Hennessey explains why moderate‑intensity exercise is both sustainable and effective, offering improvements in cardiovascular function, metabolism, and daily energy levels. The discussion explores the benefits of walking versus running, how heart rate zones help guide workout intensity, and the importance of rest and active recovery. Dr. Hennessey also highlights how movement helps regulate stress and why strength training—especially for women—is essential for long‑term metabolic and bone health. Chapters:Chapter 1: Understanding Cozy Cardio – Convenience, Comfort, and Where it Fits in Heart HealthUnderstanding cozy cardio and how low‑impact movement supports heart health, and how it lowers barriers to exercise and makes movement feel inviting.Chapter 2: Why Moderate Exercise MattersChapter 3: Cozy Doesn't Mean Easy—Just AccessibleChapter 4: Walking vs. Running: Which Is Better for the Heart?Chapter 5: Using Heart Rate to Guide Your WorkoutChapter 6: The Importance of Rest Days and RecoveryChapter 7: HIIT: Benefits, Risks, and When to Use ItChapter 8: Strength Training & Heart Health, Especially for WomenChapter 9: Building a Sustainable Exercise RoutineChapter 10: Final Takeaway Key Topics CoveredWhat cozy cardio is and examplesHow cozy cardio focuses on convenience, comfort and lowering barriers to exercise.Moderate vs. High-Intensity ExerciseHow it can improve VO2 maxAccessibility and sustainability in fitnessWalking vs. runningUsing heart rate as a guide for exerciseThe importance of rest daysExercise as stress reductionHIIT workouts: explanation, benefits and riskStrength training and heart healthBuilding a sustainable routine by choosing activities you enjoy and making movement a natural part of the dayTakeaway MessageMeaningful improvements in cardiovascular health do not require high‑intensity workouts. Moderate, accessible forms of exercise—such as “cozy cardio”—can effectively enhance heart and metabolic function, support stress regulation, and promote long‑term adherence. By prioritizing comfort, sustainability, and consistency, individuals can integrate movement into their daily routines in ways that are both achievable and beneficial for overall health.Expert GuestDr. Jessica Hennessey is an electrophysiologist who specializes in arrhythmia management with a special focus on catheter ablation, pacemakers/defibrillators, and atrial fibrillation at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Hennessey is also the Esther Aboodi Assistant Professor of Cardiology (in medicine) at Columbia University Vagelos College of Physicians and Surgeons. She is board-certified in cardiovascular disease and cardiac electrophysiology.For more health and wellness news, visit NewYork-Presbyterian's Health Matters website. 

Those who hope to honor God and advance Jesus' Kingdom face powerful opposition from spiritual, physical, and psychological enemies. Successful launching and long term fruitfulness depends on recognizing and, in dependence on the Holy Spirit, waging war against those enemies.

"If you ask the surgeon how much time they have to spend thinking about the business side of their practice, it's too high... Let's let doctors be doctors." - Ryan WellsMy guest this week is Ryan Wells, Founder and CEO of Health Here. Ryan joins me to explain why the key to fixing the broken doctor-patient relationship is getting providers out of the debt collection business.We explore how Episodic Care (bundled payments) can finally align the financial incentives of self-funded employers and high-value specialists. Ryan breaks down how his platform automates payments, getting surgeons paid in under 15 days while eliminating patient liability entirely.We dive deep into Ryan's background in the OR, the lessons learned from the "Metal on Metal" hip recall, and why we need to move from "open enrollment confusion" to real-time, event-driven patient navigation.If you are tired of administrative waste and want to see a model where doctors focus on care instead of claims, this episode is for you.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit ParetoHealth.com to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Let Doctors Be Doctors(00:03:04) Ryan's Journey: From Anthropology to the OR (00:07:00) Lessons from Medicare's Acute Care Episode Demo (00:10:46) Defining the "Bundle" vs. Fee-for-Service (00:13:00) Value-Based Care = Outcome / Cost (00:16:14) Why Orthopedics is the Perfect Starting Point (00:18:32) Moving from "Elective" to "Discretionary" Care (00:21:38) The Navigation Problem: Open Enrollment Fails (00:31:48) Owning the Payment Rails: 15-Day Payments (00:37:38) Automating the "Outlier Workflow" (00:41:35) The "Metal on Metal" Hip Recall & Registries (00:48:30) Expanding to Cardiology and Bariatrics (00:53:03) The Moonshot: Removing the Business Burden from MDsKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I PREVENT Score PREVENT Equations in Young Adults https://doi.org/10.1016/j.jacc.2025.12.019 Hospital Readmission Reduction Program for HF https://pmc.ncbi.nlm.nih.gov/articles/PMC7664458/ II A New Breakthrough in LDL-C Management With an Oral PCSK9 Inhibitor https://www.medscape.com/viewarticle/time-overcome-pcsk9i-inertia-new-data-future-options-2025a1000wf8 CORALreef Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2511002 CORALreef Outcomes Trial https://clinicaltrials.gov/study/NCT06008756 III A Win for the Factor XI Inhibitor Asundexian – OCEANIC Stroke Trial https://www.medscape.com/viewarticle/first-clear-win-factor-xia-inhibitors-stroke-reduced-2026a10003t0 OCEANIC-STROKE Slide deck https://clinicaltrialresults.org/wp-content/uploads/2026/02/26-02-02_ISC_OCEANIC-STROKE-primary.pdf OCEANIC-AF Study Stopped Early https://www.bayer.com/media/en-us/oceanic-af-study-stopped-early-due-to-lack-of-efficacy/ IV Statin Side Effects Assessment of AEs Attributed to Statins -- Meta-analysis https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01578-8/fulltext N-of-1 Trial to Assess AEs of Statins https://www.nejm.org/doi/full/10.1056/NEJMc2031173 When to Start a Statin Is a Decision About Preference -- Editorial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.117.029808 V Heart Disease Statistics CV Statistics in the US, 2026 https://www.jacc.org/doi/10.1016/j.jacc.2025.12.027 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we replay an episode from nearly 2 years ago about an editorial commentary from multiple congenital heart surgical leaders in the US. The topic of their expert opinion piece is the concept of public reporting of results and their 'amplification' through organizations such as US News and World Report, to name one. How has the use of the database from STS been sometimes misinterpreted through public reporting or ranking systems? What was the initial intent of the STS database and how does the present usage of these data differ from the initial intent? Do STS risk adjustment models capture all aspects of risk for patients undergoing surgery and how do deficiencies in this result in unfair 'rankings' of programs? Can we 'take control' of our data and interpret it more clearly and accurately for the public and reduce misusage or misinterpretation of the data? How can public reporting result in improved outcomes? How can 'gaming' of the system be reduced? Dr. Emile Bacha, Professor of Surgery at Columbia University shares his deep insights into a complex and challenging topic.DOI: 10.1016/j.jtcvs.2023.03.022

The 2026 updates introduced new and revised PCI CPT codes, and even experienced coders are feeling the impact. With fresh code options and shifting applications, accurately capturing Coronary Intervention services—and protecting revenue—has become more challenging. In this episode, Terry breaks down what's changed, how to navigate the nuances, and what you need to know about bundling rules to stay compliant and confident. Subscribe and Listen Find all of Terry's official links in one place: https://www.terryfletcher.net/links The post Cardiology PCI Coding Made Clear appeared first on Terry Fletcher Consulting, Inc..

Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an AI-enhanced diagnostic tool in the office are the topics discussed by John Mandrola, MD, in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Risk-Based TEE Omission in PVI 10.1016/j.hrthm.2025.04.056 External Link II PFA News BEAT PAROX-AF trial https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf1115/8436829 Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After PFA https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.125.077983 Heart Rhythm TV: Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias  https://www.youtube.com/watch?v=M-npoLKmRa4 MAUDE Adverse Event report https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=23733351&pc=QZI III Obesity trends US State-Level Obesity Trends 1990-2022 and Forecasted to 2035 https://jamanetwork.com/journals/jama/fullarticle/2844495 IV New Tools in the Office TRICORDER Trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02156-7/fulltext You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This week we review a recent work on fetal atrial septal interventions in the patient with hypoplastic left ventricle or double outlet right ventricle with mitral valve atresia/dysplasia and a restrictive or intact atrial septum. How often was this procedure technically feasible and successful? What are the criteria to be considered for such an intervention? Why does use of a laser improve the crossing of the atrial septum in this procedure? Should prenatal intervention be used instead of postnatal intervention in this setting? Associate Professor of Pediatrics at Baylor College of Medicine, Dr. Betul Yilmaz shares her insights into this fascinating topic.https://doi.org/10.1161/CIRCINTERVENTIONS.125.015209

The WHOOP Podcast Longevity Series is back! This week, WHOOP SVP of Research, Algorithms, and Data, Emily Capodilupo sits down with Dr. Ami Bhatt, renowned cardiologist, Chief Innovation Officer at the American College of Cardiology, and the first-ever Chair of Digital Health at the FDA. Dr. Bhatt offers a rare, inside look at how medicine, technology, and policy are coming together to enhance the future of healthcare. From wearables to AI to patient agency and clinician training, this conversation unpacks what it takes to modernize healthcare. Dr. Bhatt shares her personal journey from practicing cardiologist to national innovation leader, highlighting the role of  education, ethics, and human-AI collaboration in creating a better healthcare landscape for patients across the country.(00:53) Intro to Dr. Ami Bhatt, First Chair of Digital Health, FDA(3:20) Seeing AI As A Tool In Healthcare(06:23) Teaching AI: Responsibility & Ethics In Healthcare(09:19) Dr. Bhatt: From Cardiology to Policy(12:21) Role As A Chief Innovation Officer in Healthcare Regulation(16:03) Adjusting Teaching Policies to AI(21:45) Thinking About Wearables: Data Translation & AI(30:38) Technology in Healthcare: Building Algorithms & Navigating FDA ApprovalFollow Dr. Ami BhattLinkedInXSupport the showFollow WHOOP: Sign up for WHOOP Advanced Labs Trial WHOOP for Free www.whoop.com Instagram TikTok YouTube X Facebook LinkedIn Follow Will Ahmed: Instagram X LinkedIn Follow Kristen Holmes: Instagram LinkedIn Follow Emily Capodilupo: LinkedIn

Listener feedback, the value of procedural volume for TAVR and MTEER, ventricular arrhythmia in older athletes, and the Goldilocks time horizon for predicting and modifying CV risk are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Procedural Volume and Outcomes for TAVI and M-TEER Operator Procedural Volumes and Outcomes for TAVR and MTEER https://jamanetwork.com/journals/jamacardiology/fullarticle/2843740 II Ventricular Arrhythmia in Older Male Endurance Athletes Myocardial Fibrosis May Raise Arrhythmia Risk in Older Male Endurance Athletes https://www.medscape.com/viewarticle/myocardial-fibrosis-may-raise-arrhythmia-risk-older-male-2026a10001y0 Timing and Relationship of VA With Exercise Patterns in Older Male Endurance Athletes https://doi.org/10.1093/eurjpc/zwag021 III Predicting Cardiac Risk and Statin Use 30-Year ASCVD Risk Among US Adults Aged 30-59 https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.125.012348 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net